Anemia, a common condition affecting nearly a third of the global population, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive diagnostic approach to anemia for healthcare professionals.
Initial assessment should focus on a thorough history and physical examination, aiming to identify signs of bleeding, malnutrition, or systemic illness. Laboratory evaluation should include complete blood count (CBC), reticulocyte count, and peripheral smear.
Anemia can be classified based on the mean corpuscular volume (MCV) into microcytic, normocytic, or macrocytic. Iron studies, vitamin B12, and folate levels can help differentiate between these types.
When initial investigations are inconclusive, further tests may be warranted. These include hemoglobin electrophoresis for suspected hemoglobinopathies, bone marrow biopsy for suspected marrow failure, and endoscopy or colonoscopy for suspected gastrointestinal bleeding.
Unraveling the complexity of anemia requires a systematic approach, beginning with a thorough history and physical examination, followed by targeted laboratory testing. Through this comprehensive approach, healthcare professionals can accurately diagnose the underlying cause of anemia, guiding appropriate treatment and improving patient outcomes.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation